Low-dose omeprazole-based triple therapy eradicates H. pylori

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1497, 2005-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-dose clarithromycin has efficacy similar to high-dose clarithromycin in omeprazole-based triple therapy for Helicobacter pylori eradication

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Efficacy of a Low-Dose Omeprazole-Based Triple-Therapy Regimen for Helicobacter pylori Eradication Independent of Cytochrome P450 Genotype: The Japanese MACH Study

By Kuwayama Hajime  

Clinical Drug Investigation, Vol. 25, Iss. 5, 2005-01 ,pp. : 293-305

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Helicobacter pylori Eradication Therapy with Omeprazole, Amoxicillin and High- and Low-Dose Clarithromycin in Japanese Patients: A Randomised, Double-Blind, Multicentre Study

By Higuchi Kazuhide  

Clinical Drug Investigation, Vol. 26, Iss. 7, 2006-01 ,pp. : 403-414

Adis International

Access to resources Recommend Favorite

PPI-based triple therapy: 7 days adequate for H. pylori eradication

By  

Inpharma, Vol. 1, Iss. 1616, 2007-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Risk Factors for Upper GI Damage in Low-Dose Aspirin Users and the Interaction Between H. pylori Infection and Low-Dose Aspirin Use

By  

Current Pharmaceutical Design, Vol. 21, Iss. 35, 2015-10 ,pp. : 5056-5065

Bentham Science Publishers

Access to resources Recommend Favorite